ETF Managers Group, LLC Kamada LTD Transaction History

ETF Managers Group, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.22 - $5.85 $43,141 - $59,804	-10,223 Reduced 19.04%	43,459 $196,000
Q1 2022 May 13, 2022	SELL	$5.43 - $6.81 $22,849 - $28,656	-4,208 Reduced 7.27%	53,682 $304,000
Q4 2021 Feb 14, 2022	SELL	$5.21 - $6.82 $45,347 - $59,361	-8,704 Reduced 13.07%	57,890 $382,000
Q3 2021 Nov 15, 2021	SELL	$5.25 - $5.87 $24,108 - $26,955	-4,592 Reduced 6.45%	66,594 $350,000
Q2 2021 Aug 16, 2021	SELL	$5.67 - $6.33 $214,904 - $239,919	-37,902 Reduced 34.74%	71,186 $420,000
Q1 2021 May 17, 2021	BUY	$6.02 - $8.06 $117,287 - $157,032	19,483 Added 21.74%	109,088 $662,000
Q4 2020 Feb 16, 2021	BUY	$6.3 - $8.46 $124,910 - $167,736	19,827 Added 28.41%	89,605 $585,000
Q3 2020 Nov 16, 2020	BUY	$8.02 - $11.73 $77,072 - $112,725	9,610 Added 15.97%	69,778 $559,000
Q2 2020 Aug 14, 2020	BUY	$5.37 - $9.45 $57,829 - $101,767	10,769 Added 21.8%	60,168 $476,000
Q1 2020 May 14, 2020	BUY	$4.56 - $7.13 $20,009 - $31,286	4,388 Added 9.75%	49,399 $278,000
Q4 2019 Feb 14, 2020	SELL	$4.97 - $7.7 $54,123 - $83,853	-10,890 Reduced 19.48%	45,011 $301,000
Q3 2019 Nov 14, 2019	BUY	$5.11 - $5.99 $29,873 - $35,017	5,846 Added 11.68%	55,901 $287,000
Q2 2019 Aug 14, 2019	SELL	$5.39 - $6.26 $5,045 - $5,859	-936 Reduced 1.84%	50,055 $270,000
Q1 2019 May 07, 2019	SELL	$5.12 - $6.18 $8,417 - $10,159	-1,644 Reduced 3.12%	50,991 $292,000
Q4 2018 Feb 01, 2019	BUY	$4.68 - $6.25 $246,331 - $328,968	52,635 New	52,635 $263,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $264M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.